Harsaul Foundation insider trades: RVL Pharmaceuticals (RVLP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Harsaul Foundation reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 20, 2023 | RVLP | ↓ Sell | 14,122,659 | $0.04 | $580K | By Self as indirect owner of Altchem Lim | Oct 23, 2023 (3d) |
| Oct 18, 2023 | RVLP | ↓ Sell | 3,421,537 | $0.06 | $221K | By Self as indirect owner of Altchem Lim | Oct 20, 2023 (2d) |
| Jan 13, 2020 | OSMT | ↑ Buy | 1,250,000 | $5.00 | $6.3M | By Self as indirect owner of Altchem Lim | Jan 15, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Harsaul Foundation's insider trades
Harsaul Foundation is a 10% owner of RVL Pharmaceuticals (RVLP). Since Jan 13, 2020, it has reported 1 open-market purchase worth $6.3M and 2 sales worth $801K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVLP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.